May M. Luke

2.2k total citations
24 papers, 1.7k citations indexed

About

May M. Luke is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, May M. Luke has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Genetics and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in May M. Luke's work include Genetic Associations and Epidemiology (8 papers), Lipoproteins and Cardiovascular Health (4 papers) and Cardiac Valve Diseases and Treatments (3 papers). May M. Luke is often cited by papers focused on Genetic Associations and Epidemiology (8 papers), Lipoproteins and Cardiovascular Health (4 papers) and Cardiac Valve Diseases and Treatments (3 papers). May M. Luke collaborates with scholars based in United States, Japan and Canada. May M. Luke's co-authors include Yasuhisa Adachi, Ulrich K. Laemmli, Kim Arndt, James J. Devlin, Dov Shiffman, Charles M. Rowland, A Sutton, Joseph J. Catanese, John P. Kane and Mary J. Malloy and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

May M. Luke

24 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
May M. Luke United States 17 886 449 289 263 203 24 1.7k
Benjamin M. Buehrer United States 22 1.1k 1.2× 177 0.4× 166 0.6× 270 1.0× 308 1.5× 32 1.8k
Martine I. Darville Belgium 25 1.0k 1.1× 834 1.9× 137 0.5× 614 2.3× 249 1.2× 36 2.2k
William D. Stuart United States 21 692 0.8× 236 0.5× 155 0.5× 106 0.4× 83 0.4× 51 1.6k
Prem M. Sharma United States 18 1.2k 1.4× 230 0.5× 119 0.4× 70 0.3× 152 0.7× 26 1.6k
J. Antonie Maassen Netherlands 21 974 1.1× 171 0.4× 47 0.2× 175 0.7× 119 0.6× 42 1.3k
Lynnetta M. Watts United States 17 1.7k 1.9× 261 0.6× 132 0.5× 113 0.4× 102 0.5× 27 2.6k
Yue Sheng China 20 786 0.9× 99 0.2× 133 0.5× 144 0.5× 169 0.8× 66 1.3k
Thomas Porstmann Switzerland 8 1.1k 1.2× 410 0.9× 42 0.1× 68 0.3× 189 0.9× 10 1.7k
Vishva M. Sharma United States 17 843 1.0× 69 0.2× 81 0.3× 160 0.6× 85 0.4× 26 1.4k
Ayce Yesilaltay United States 18 503 0.6× 409 0.9× 103 0.4× 67 0.3× 93 0.5× 20 1.0k

Countries citing papers authored by May M. Luke

Since Specialization
Citations

This map shows the geographic impact of May M. Luke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May M. Luke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May M. Luke more than expected).

Fields of papers citing papers by May M. Luke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by May M. Luke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May M. Luke. The network helps show where May M. Luke may publish in the future.

Co-authorship network of co-authors of May M. Luke

This figure shows the co-authorship network connecting the top 25 collaborators of May M. Luke. A scholar is included among the top collaborators of May M. Luke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with May M. Luke. May M. Luke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iakoubova, Olga A., Carmen H. Tong, Joseph J. Catanese, et al.. (2016). KIF6 719Arg Genetic Variant and Risk for Thoracic Aortic Dissection. Aorta. 4(3). 83–90. 9 indexed citations
2.
Rowland, Charles M., Clive R. Pullinger, May M. Luke, et al.. (2014). Lipoprotein (a), LPA Ile4399Met, and Fibrin Clot Properties. Thrombosis Research. 133(5). 863–867. 27 indexed citations
3.
Iakoubova, Olga A., Carmen H. Tong, Charles M. Rowland, et al.. (2014). Genetic Variants in FBN-1 and Risk for Thoracic Aortic Aneurysm and Dissection. PLoS ONE. 9(4). e91437–e91437. 24 indexed citations
4.
Ellis, Stephen G., May M. Luke, Gurunathan Murugesan, et al.. (2012). Pilot Candidate Gene Analysis of Patients ≥60 Years Old With Aortic Stenosis Involving a Tricuspid Aortic Valve. The American Journal of Cardiology. 110(1). 88–92. 12 indexed citations
5.
Luke, May M., Klaus Berger, Charles M. Rowland, et al.. (2011). Polymorphisms and Noncardioembolic Stroke in Three Case-Control Studies. Cerebrovascular Diseases. 33(1). 80–85. 2 indexed citations
6.
Li, Yonghong, May M. Luke, Dov Shiffman, & James J. Devlin. (2011). Genetic Variants in the Apolipoprotein(a) Gene and Coronary Heart Disease. Circulation Cardiovascular Genetics. 4(5). 565–573. 52 indexed citations
7.
Arai, Kiyohito, May M. Luke, Marlys L. Koschinsky, et al.. (2009). The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles. Atherosclerosis. 209(2). 498–503. 33 indexed citations
8.
Luke, May M., Wolfgang Lalouschek, Charles M. Rowland, et al.. (2009). Polymorphisms Associated with Both Noncardioembolic Stroke and Coronary Heart Disease: Vienna Stroke Registry. Cerebrovascular Diseases. 28(5). 499–504. 24 indexed citations
9.
Chasman, Daniel I., Dov Shiffman, Robert Y.L. Zee, et al.. (2008). Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy. Atherosclerosis. 203(2). 371–376. 170 indexed citations
10.
Morrison, Alanna C., Lance A. Bare, May M. Luke, et al.. (2008). Single Nucleotide Polymorphisms Associated with Coronary Heart Disease Predict Incident Ischemic Stroke in the Atherosclerosis Risk in Communities Study. Cerebrovascular Diseases. 26(4). 420–424. 15 indexed citations
11.
Bare, Lance A., Alanna C. Morrison, Charles M. Rowland, et al.. (2007). Five common gene variants identify elevated genetic risk for coronary heart disease. Genetics in Medicine. 9(10). 682–689. 75 indexed citations
12.
Ellis, Stephen G., et al.. (2007). Relation of Polymorphisms in Five Genes to Long-Term Aortocoronary Saphenous Vein Graft Patency. The American Journal of Cardiology. 99(8). 1087–1089. 10 indexed citations
13.
Shiffman, Dov, Ellen S. O’Meara, Lance A. Bare, et al.. (2007). Association of Gene Variants With Incident Myocardial Infarction in the Cardiovascular Health Study. Arteriosclerosis Thrombosis and Vascular Biology. 28(1). 173–179. 126 indexed citations
14.
Shiffman, Dov, Stephen G. Ellis, Charles M. Rowland, et al.. (2005). Identification of Four Gene Variants Associated with Myocardial Infarction. The American Journal of Human Genetics. 77(4). 596–605. 132 indexed citations
15.
Kane, John P., Bradley E. Aouizerat, May M. Luke, et al.. (2004). Novel genetic markers for structural coronary artery disease, myocardial infarction, and familial combined hyperlipidemia: candidate and genome scans of functional SNPs. International Congress Series. 1262. 309–312. 5 indexed citations
16.
Johnson, Paul H., Roger P. Walker, Steven W. Jones, et al.. (2002). Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cells.. PubMed. 1(14). 1293–304. 53 indexed citations
17.
Luke, May M., et al.. (1996). The SAPs, a New Family of Proteins, Associate and Function Positively with the SIT4 Phosphatase. Molecular and Cellular Biology. 16(6). 2744–2755. 136 indexed citations
18.
Zhong, Tao, May M. Luke, & Kim Arndt. (1996). Transcriptional Regulation of the Yeast DnaJ Homologue SIS1. Journal of Biological Chemistry. 271(3). 1349–1356. 14 indexed citations
19.
Adachi, Yasuhisa, May M. Luke, & Ulrich K. Laemmli. (1991). Chromosome assembly in vitro: Topoisomerase II is required for condensation. Cell. 64(1). 137–148. 339 indexed citations
20.
Luke, May M. & Daniel Bogenhagen. (1989). Quantitation of type II topoisomerase in oocytes and eggs of Xenopus laevis. Developmental Biology. 136(2). 459–468. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin M. Buehrer Breakdown of academic impact, for papers by Martine I. Darville Breakdown of academic impact, for papers by William D. Stuart Breakdown of academic impact, for papers by Prem M. Sharma Breakdown of academic impact, for papers by J. Antonie Maassen Breakdown of academic impact, for papers by Lynnetta M. Watts Breakdown of academic impact, for papers by Yue Sheng Breakdown of academic impact, for papers by Thomas Porstmann Breakdown of academic impact, for papers by Vishva M. Sharma Breakdown of academic impact, for papers by Ayce Yesilaltay
Rankless by CCL
2026